Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Elekta AB ( ($SE:EKTA.B) ) is now available.
Elekta has announced significant changes in its executive management, appointing Klara Eiritz as the new Chief Financial Officer, effective by March 2026, while the current CFO, Chief Commercial Officer, and Chief People Officer will leave the company. These changes are part of a strategic restructuring to enhance leadership capabilities and streamline operations, with the goal of improving commercial execution, responding more effectively to customer needs, and delivering sustainable shareholder value.
The most recent analyst rating on ($SE:EKTA.B) stock is a Sell with a SEK34.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.
More about Elekta AB
Elekta is a leader in precision radiation therapy, dedicated to providing the best cancer care through innovative, sustainable, and cost-efficient solutions. With a global team of 4,500 employees, Elekta aims to improve patient outcomes and is headquartered in Stockholm, Sweden, with operations in over 40 countries.
YTD Price Performance: -24.03%
Average Trading Volume: 997,272
Technical Sentiment Signal: Sell
Current Market Cap: SEK16.93B
For detailed information about EKTA.B stock, go to TipRanks’ Stock Analysis page.